Literature DB >> 18821149

Evaluation of the role of peroxisome proliferator-activated receptor alpha (PPARalpha) in mouse liver tumor induction by trichloroethylene and metabolites.

J Christopher Corton1.   

Abstract

Trichloroethylene (TCE) is an industrial solvent and a widespread environmental contaminant. Induction of liver cancer in mice by TCE is thought to be mediated by two metabolites, dichloroacetate (DCA) and trichloroacetate (TCA), both of which are themselves mouse liver carcinogens. TCE, TCA, and DCA are relatively weak peroxisome proliferators (PP), a group of rodent hepatocarcinogens that activate a nuclear receptor, PP-activated receptor alpha (PPARalpha. The objective of this review is to assess the weight of evidence (WOE) that PPARalpha is or is not mechanistically involved in mouse liver tumor induction by TCE and metabolites. Based on similarities of TCE and TCA to typical PP, including dose-response characteristics showing PPARalpha-dependent responses coincident with liver tumor induction and abolishment of TCE and TCA effects in PPARalpha-null mice, the WOE supports the hypothesis that PPARalpha plays a dominant role in TCE- and TCA-induced hepatocarcinogenesis. Data indicates that the MOA for DCA tumor induction is PPARalpha-independent. Uncertainties remain regarding the genesis of the TCE-induced tumors. In contrast to the TCA-induced tumors, which have molecular features similar to those induced by typical PP, there is evidence, albeit weak, that TCE tumors arise by a mode of action (MOA) different from that of TCA tumors, based largely on dissimilarities in molecular markers found in TCE versus TCA-induced tumors. In summary, the WOE indicates that TCA-induced liver tumors arise by a PPARalpha-dependent MOA. Although the TCE MOA is likely dominated by a PPARalpha-dependent contribution from TCA, the contribution of a PPARalpha-independent MOA from DCA cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18821149     DOI: 10.1080/10408440802209796

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  19 in total

1.  Impact of Nonalcoholic Fatty Liver Disease on Toxicokinetics of Tetrachloroethylene in Mice.

Authors:  Joseph A Cichocki; Shinji Furuya; Kranti Konganti; Yu-Syuan Luo; Thomas J McDonald; Yasuhiro Iwata; Weihsueh A Chiu; David W Threadgill; Igor P Pogribny; Ivan Rusyn
Journal:  J Pharmacol Exp Ther       Date:  2017-02-01       Impact factor: 4.030

2.  PBPK modeling of impact of nonalcoholic fatty liver disease on toxicokinetics of perchloroethylene in mice.

Authors:  Chimeddulam Dalaijamts; Joseph A Cichocki; Yu-Syuan Luo; Ivan Rusyn; Weihsueh A Chiu
Journal:  Toxicol Appl Pharmacol       Date:  2020-05-21       Impact factor: 4.219

3.  Editor's Highlight: Collaborative Cross Mouse Population Enables Refinements to Characterization of the Variability in Toxicokinetics of Trichloroethylene and Provides Genetic Evidence for the Role of PPAR Pathway in Its Oxidative Metabolism.

Authors:  Abhishek Venkatratnam; Shinji Furuya; Oksana Kosyk; Avram Gold; Wanda Bodnar; Kranti Konganti; David W Threadgill; Kevin M Gillespie; David L Aylor; Fred A Wright; Weihsueh A Chiu; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2017-07-01       Impact factor: 4.849

4.  The Contribution of Peroxisome Proliferator-Activated Receptor Alpha to the Relationship Between Toxicokinetics and Toxicodynamics of Trichloroethylene.

Authors:  Hong Sik Yoo; Joseph A Cichocki; Sungkyoon Kim; Abhishek Venkatratnam; Yasuhiro Iwata; Oksana Kosyk; Wanda Bodnar; Stephen Sweet; Anthony Knap; Terry Wade; Jerry Campbell; Harvey J Clewell; Stepan B Melnyk; Weihsueh A Chiu; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2015-07-01       Impact factor: 4.849

5.  Interstrain differences in the liver effects of trichloroethylene in a multistrain panel of inbred mice.

Authors:  Blair U Bradford; Eric F Lock; Oksana Kosyk; Sungkyoon Kim; Takeki Uehara; David Harbourt; Michelle DeSimone; David W Threadgill; Volodymyr Tryndyak; Igor P Pogribny; Lisa Bleyle; Dennis R Koop; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2010-12-06       Impact factor: 4.849

Review 6.  Nuclear receptors and nonalcoholic fatty liver disease.

Authors:  Matthew C Cave; Heather B Clair; Josiah E Hardesty; K Cameron Falkner; Wenke Feng; Barbara J Clark; Jennifer Sidey; Hongxue Shi; Bashar A Aqel; Craig J McClain; Russell A Prough
Journal:  Biochim Biophys Acta       Date:  2016-03-04

7.  Comparative analysis of the relationship between trichloroethylene metabolism and tissue-specific toxicity among inbred mouse strains: liver effects.

Authors:  Hong Sik Yoo; Blair U Bradford; Oksana Kosyk; Svitlana Shymonyak; Takeki Uehara; Leonard B Collins; Wanda M Bodnar; Louise M Ball; Avram Gold; Ivan Rusyn
Journal:  J Toxicol Environ Health A       Date:  2015

8.  Transcriptional changes associated with reduced spontaneous liver tumor incidence in mice chronically exposed to high dose arsenic.

Authors:  Gail M Nelson; Gene J Ahlborn; James W Allen; Hongzu Ren; J Christopher Corton; Michael P Waalkes; Kirk T Kitchin; Bhalchandra A Diwan; Geremy Knapp; Don A Delker
Journal:  Toxicology       Date:  2009-10-12       Impact factor: 4.221

Review 9.  The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions.

Authors:  J Christopher Corton; Jeffrey M Peters; James E Klaunig
Journal:  Arch Toxicol       Date:  2017-12-02       Impact factor: 5.153

Review 10.  Peroxisome Proliferator-Activated Receptors and Their Agonists in Nonalcoholic Fatty Liver Disease.

Authors:  Narendra S Choudhary; Naveen Kumar; Ajay Duseja
Journal:  J Clin Exp Hepatol       Date:  2019-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.